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doi:10.1016/j.ejvs.2011.03.017Abstract Objective: In this histological study, the role of the intraluminal blood during endo-
venous laser ablation was assessed.
Methods: In 12 goats, 24 lateral saphenous veins were treated with a 1500-nm diode laser. Four
goats were treated in an anti-Trendelenburg position (group 1). The next four goats were
treated in a Trendelenburg position (group 2) and the remaining four goats in the Trendelen-
burg position with additional injection of tumescent liquid (group 3). Postoperatively, the veins
were removed after 1 week and sent for histological examination. We measured the number of
perforations. Vein wall necrosis and the perivenous tissue destruction were quantified using
a graded scale.
Results: The ‘calculated total vein wall destruction’ was significantly higher in the third group
(81.83%), as compared with groups one (61.25%) (p < 0.001) and two (65.92%) (p < 0.001). All
three groups showed a significant difference in the perivenous tissue destruction scale
(p < 0.001) with the lowest score occurring in the third group. Vein wall perforations were
significantly more frequent in groups one and two as compared with the third group (T-test
respectively p < 0.001, p Z 0.02).
Conclusion: A higher intraluminal blood volume results in reduced total vein wall destruction.
Injection of tumescent liquid prevents the perivenous tissue destruction and minimises the
number of perforations.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.42 5060; Fax:+32 5142 5061.
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Endovenous Laser Ablation 121Endovenous laser ablation (EVLA) is a very popular mini-
mally invasive alternative to surgical vein stripping in the
treatment of saphenous vein reflux. After catheterising the
saphenous vein and introducing a laser fibre into the lumen,
light energy is delivered within the vein. This energy is
absorbed by the intraluminal blood, water or the vein wall.
The aim of this technique is to irreversibly obliterate the
treated vein. Long-term occlusion rates in saphenous veins
in between 87% and 100% have been reported.1e4 These
endovenous lasers are commonly classified into two groups:
one in which there is a higher absorption coefficient for
oxyhaemoglobin5e8 (810e940e980-nm lasers) and a second
one in which the energy is preferentially absorbed by
water9e12 (1320e1470e1500-nm diode laser). In all used
wavelengths, the optical extinction is very similar for blood
and for water.13,14 Only the energy is 5e7 times more
selective absorbed at the higher wavelengths.12 So
conclusions about the role of the intraluminal blood using
a 1500 nm diode laser also account for the use of lower-
wavelengths lasers.
Many studies have been based on the assumption that
during EVLA, the vein is filled with blood. In the light of
clinical experience, the presence of blood inside the vein
has a number of consequences.15e17
 Blood around the fibre tip reduces the transmission of
light to the biological target of EVLA, the venous wall.18
Since thermal damage to the inner vein wall (tunica
intima) is required to achieve the tissue alterations
necessary for permanent vein occlusion, the presence
of blood greatly impairs the effect of the laser on the
vessel wall. If the laser light energy is entirely absorbed
by the blood, the initial success rate will be mainly due
to a thrombotic effect; but thrombus dissolution will
then lead to recanalisation, as clearly demonstrated by
Proebstle et al.19
 The presence of blood can generate steam bubbles. The
formation of these steam bubbles has been confirmed by
Proebstle et al. who have observed that they were
generated in haemolytic blood by 810-, 940- and 980-nm
diode lasers, whereas no bubbles were produced in
normal saline or plasma.20 This mechanism is now,
however, considered to be of secondary importance to
the efficacy of EVLA.21,22
 Last, but not least, the presence of blood induces car-
bonisation at the fibre tip and often melting of the glass
fibre tip. This phenomenon implies fibre tip tempera-
tures in excess of 1200 C. This melting point of the glass
fibre tip has been observed by Fan and Rox-Anderson.22
The partial destruction of the tip compromises beam
homogeneity leading to an unpredictable pattern of
energy distribution inside the vein. Furthermore, the
carbon layer that rapidly forms at the tip absorbsmost of
the light energy and converts it into heat, radically
altering the laser/tissue interaction process.
Variability in the amount of blood within the vein leads
to inconsistent results. In our experience, the vein lumen is
emptied of its blood by using leg elevation (Trendelenburg
positioning) and perisaphenous subcutaneous tumescent
saline solution infiltration. This solution containing local
anaesthetic serves three purposes. First, the vein itself andthe surrounding tissues are anaesthetised. Second, the fluid
around the vein helps to protect the surrounding tissues
from any collateral injury from the heat of the laser. Third,
the fluid exerts compression around the vein and induces
spasm. This helps to empty the vein of its contents.
Until now, although it is assumed that the intraluminal
blood can alter the efficacy of EVLA, no histological studies
can be identified concerning the role of blood during in vivo
EVLA. The objective of this histological trial is to assess the
consequences of the presence of the intraluminal blood.Materials and MethodsMaterials and techniques
Our investigation was approved by the ethics committee for
animal experiments at the Catholic University of Leuven,
Belgium. Goat saphenous veins were used since the lateral
saphenous vein has a mean diameter of 4e6 mm in the
supine position, which is comparable to that of human veins.
Using 12 goats, 24 lateral saphenous veins were treated
with EVLA. The goats were treated under general anaes-
thesia. Under ultrasound control (Mindray M5 ultrasound,
Shenzen, China), access was achieved by puncture of the
distal part of the lateral saphenous vein. A sheath was
introduced and a 600-mm tulip fibre (Tobrix, Waalre, the
Netherlands) was placed near the saphenofemoral
junction. This tulip fibre consists of a hollow tube, fixed to
the laser fibre. This tube has tulip-shaped self-expandable
blades at its distal end and is made of stainless steel. When
the blades expand, they push away the vein wall and thus
centre the fibre tip intraluminal.23 The reason for using this
tulip fibre was to avoid direct contact between the fibre tip
and the vein wall (see discussion). We divided the sample
into three distinct groups with different amounts of intra-
venous blood. Four goats (eight veins) were treated in an
anti-Trendelenburg position (group one), which was in
order to maximise the amount of intraluminal blood. The
next four goats were treated in a Trendelenburg position
(group two) and the remnant four goats in Trendelenburg
position with additional injection of tumescent liquid
around the target vein (group three). This tumescent liquid
is physiological saline (at 36 C). Injection was performed
under ultrasound control and the target vein was sur-
rounded by the liquid. On average, 90 ml was injected
around the veins, equivalent to 5.8 ml cm1. Veins were
treated with a 1500-nm diode laser (Inter-Medic, Barce-
lona, Spain), using a continuous pullback protocol. Power
was set to 5 W and pullback speed was adjusted to deliver
a linear endovenous energy density (LEED)24 between 45
and 50 J cm1.
Postoperatively, all the veins were completely surgically
removed, including perivenous tissue, 1 week after treat-
ment and sent for histological examination. About 14
sections of each vein were taken at random. The patholo-
gists measured both vein wall necrosis and the perivenous
tissue destruction, as described below. All the scoring has
been done by one pathologist, who was blind to the study
group. The other pathologist assisted, as a second opinion,
in scoring in a limited number of sections.
122 M.E. Vuylsteke et al.Measurement of vein wall necrosis
Each vein wall is divided into three layers: the intima, the
media and the adventitia. For each layer, the circumfer-
ential necrosis was measured and expressed as
a percentage of the total circumference (Fig. 1). For each
section, these three measured percentages were added
together and divided by three. The obtained result is
proposed as the ‘total vein wall necrosis score’ and varies
from 0 to 100.
Perivenous tissue destruction scale (PVTD) (Fig. 2)
The lateral saphenous vein in a goat is surrounded by
a fascia. Perivenous tissue destruction was measured at
three different points at the edge of the vein, located
120 apart. The distance between the vein wall and the
surrounding fascia was divided into three equal layers.
The extent of necrosis was graded according to the
following scale: 0 Z no necrosis, 1 Z necrosis. If any
extrafascial necrosis was seen, an additional score of 2
was added. Extra fascial necrosis correlates with more
significant perivenous tissue destruction that justifies the
additional score. Therefore, in one position the maximal
score is 5 .
Consequently, if the necrosis was seen in all three posi-
tions, the maximum necrosis score would be equal to 15.
Measurements of perivenous temperature
The temperature in the perivenous tissue was measured
using thermocouples (thermocouple type K,TJC100-CASS-
M050E-150 Omega Engineering Limited, Manchester, UK).
Four needles were inserted around the target vein, this
from distal to proximal. The needle tip of the thermocou-
ples was located in the immediate proximity of the vein
wall. Their position was checked by perioperative ultra-
sound. The thermocouples were connected to a 10-channel
22-bit DAS system (Omega Engineering, Manchester, UK)
and the temperatures curves were controlled in real time
using OMB-DAQ-SW-PLUS software (Omega Engineering) on
a Laptop (MacBook Pro, Apple Inc, California, USA). The
temperature was measured during fibre withdrawal to
determine the maximum temperature for the three groups.Figure 1 Measurement of the vein wall destruction: from the 3 la
the total circumference.Statistical evaluation
Statistical analysis was performed using SPSS 16.0 (Statis-
tical Package for the Social Sciences). We used the
Spearman correlation test for correlation analysis. Inter-
group variances for unpaired continuous and ordinal data
were evaluated non-parametrically using the Man-
neWhitney U test for goat clinical data analysis and the
Student’s T-test for histological score analysis. A signifi-
cance a-level of 0.05 was used.ResultsGoats’ clinical data
Twelve goats were treated according to the protocol
described above. The mean diameter of the veins was
0.45 cm (SD: 0.07) measured in the supine position. The
treated vein segments had on average a length of 15.6 cm
(SD: 3.8) and there was no significant difference between
the groups. The used energy (LEED and fluence) was not
different in the three groups (Table 1). After catheter-
isation and tumescent injection in the third group, the
diameter of the veins was reduced due to spasm. Before
treatment (after catheterisation, and in case injection of
the tumescence liquid) the average measured diameter of
the veins was for groups 1, 2 and 3, respectively: 0.41 cm
(SD: 0.13), 0.37 cm (SD: 0.11) and 0.20 cm (SD: 0.09). We
found a significantly higher diameter reduction in the third
group as compared to groups one and two (ManneWhitney
U, p Z 0.001).Temperature measurements
The observed temperature increase around the treated
vein during fibre pullback was very variable. Some ther-
mocouples showed no temperature increase, while others
showed a steep climb to a maximum varying between 36
and 102 C. We could not find any significant difference
between the groups.yers the necrose is measured and expressed as a percentage of
Figure 2 Perivenous Tissue Destruction scale (PVTD): the perivenous destruction is measured at three points. The distance
between the edge of the outer vein wall and the surrounding fascia is divided into three equal parts. An additional measurement of
necrosis was done at the extrafascial tissue.
Endovenous Laser Ablation 123Histological results
All veins were harvested 1 week after treatment and sent
for histological examination. A total of 329 sections of the
veins (n Z 24) were made.
Several ‘perforations’ (Fig. 3) of the treated veins were
noted. These were significantly more frequent in groups
one and two compared to the third group (T-test respec-
tively p < 0.001, pZ 0.02). The difference between groups
one and two was marginally significant (pZ 0.04) (Table 2).
In the vast majority of all sections, a homogeneous
endothelial destruction was noted. In group one, this
‘intimal destruction’ encompassed an average of 85.77% of
the circumference. In groups 2 and 3, the percentages were
87.73% and 97.96% of the circumference, respectively.
Again, we found a statistical significant difference between
the third group and the other groups (p < 0.001). Major
parts of the vein wall were destroyed and the muscle cells
were necrotic. Some sections showed vacuolisation of
the muscular layer (Fig. 4). When we look at the
‘calculated total vein wall destruction’ a significantly
higher percentage of vein wall destruction in the third
group (81.83%) was noted, as compared with groups 1
(61.25%) (p < 0.001) and 2 (65.92%) (p < 0.001).
We could not find any significant difference in total vein
wall destruction between groups 1 and 2 (p Z 0.23).
Around the treated veins, we observed a necro-
inflammatory process of new small vessels with migration
of fibroblasts and phagocytes, as previously described.18,23Table 1 Goats clinical data.
Position Mean
diameter
MDAC Le
Group 1
(n Z 8)
Anti-Trendelenburg 0.47 cm
(SD Z 0.09)
0.41 cm
(SD Z 0.13)
15
(SD
Group 2
(n Z 8)
Trendelenburg 0.44 cm
(SD Z 0.08)
0.37 cm
(SD Z 0.11)
16.
(SD
Group 3
(n Z 8)
Trendelenburg þ
tumescence
0.44 cm
(SD Z 0.04)
0.20 cm
(SD Z 0.09)
15.
(SD
MDAC: mean diameter of the veins after catheterisation, positioning
volume: volume of blood calculated using MDAC, length and withdrawSome perivenous structures also showed necrosis and were
infiltrated by this newly formed inflammatory tissue.
Interestingly, this inflammatory tissue preferentially infil-
trates the partly destroyed tissues. Even perivenous
co-axial veins or nerves can be damaged (Figs. 5 and 6).
This perivenous tissue destruction was found to be signifi-
cantly greater in group two. All three groups show a signif-
icant difference in the PVTD scale (p < 0.001) with a lowest
score in the third group (PVTD Z 5.83).Discussion
EVLA of the incompetent saphenous vein is safe and
effective. Nevertheless, discussions are still continuing
about the way of acting and especially about the role of the
intraluminal blood. Proebstle stated that the intraluminal
blood has a key role in energy absorption, resulting in the
formation of steam bubbles, which can heat up the vein
wall.8,20 Clinical studies have shown, however, that
emptying the vein of its contents results in a significantly
higher occlusion rate.15,16 Using a bare fibre allows a direct
contact between the fibre tip and the vein wall resulting in
ulcerations and perforations, due to the convection of heat
in the vein wall.18,22,23
This direct contact results in an uneven vein wall
destruction18,24 and more perivenous tissue damage.23 To
avoid these ulcerations and direct heat convection in the
vein wall, we used the tulip fibre in this trial.ngth RIBV/cm
length
LEED Fluence
(after catheterisation)
cm
Z 3.1)
O.12 cm3
(SD Z 0.09)
44.67 J/cm
(SD Z 3.5)
37.11 J/cm2
(SD Z 11.6)
3 cm
Z 3.0)
0.07 cm3
(SD Z 0.08)
44.19 J/cm
(SD Z 4.8)
38.86 J/cm2
(SD Z 10.1)
5 cm
Z 3.8)
0.00 cm3
(SD Z 0.02)
45.97J/cm
(SD Z 4.9)
72.25 J/cm2
(SD Z 7.7)
and liquid injection (group 3) RIBV: remnant intraluminal blood
ing the catheter volume.
Figure 3 Perforation of the treated vein, complete trans-
mural vein wall necrosis (vein 12, group 2).
Figure 4 Vacuolisation of the muscular layer of the vein wall
(vein 13, group 2).
124 M.E. Vuylsteke et al.Nevertheless, we did find some perforations in the
treated veins. Some of the perforations identified may have
been due to the injection of tumescent fluid and the
punctures used to position the thermocouples.
We did not find the common carbonised tracts, ulcera-
tions and small perforations like we did in veins treated
with a bare fibre (direct contact).18,23 Here, the
morphology was different showing vacuolisation of the vein
wall and in some cases a complete implosion of the vein
(Fig. 7).
A probable explanation of the origin of perforations is the
fact that the delivered energy in using the 1500-nm laser
was too high for these goat veins. The optical extinction
coefficient at this wavelength is 5e7 times higher for blood
and for water as compared to the more commonly used 980-
nm diode laser.12 In terms of volume, the energy deposited
per unit of volume is increased by a factor 43 (calculated by
S. Mordon using a Monte-Carlo program).25,26 The same
energy acts on a volume 43 times smaller and so exposes
a risk of overdose and thus of perforation. We found many
vacuoles in the muscular layer (Fig. 4), which is the result of
intense thermal destruction. If this thermal destruction
becomes too intense, a perforation or a bursting (Figs. 3 andTable 2 Histological destruction data of the three groups. Gr
position, Group 3: Trendelenburg position þ Tumescence.
Perforation Intimal
destruction
Media
destruction
Group 1
(n Z 110)
n Z 27 85.77%
(SD Z 26.32)
60.50%
(SD Z 33.68
Group 2
(n Z 110)
n Z 15 87.73%
(SD Z 19.75)
64.23
(SD Z 31.35
Group 3
(n Z 109)
n Z 5 97.98%
(SD Z 8.25)
82.94%
(SD Z 25.65
P-value
(T-test)
p* Z 0.04 p* Z 0.54 p* Z 0.40
p**<0.001 p**<0.001 p**<0.001
p*** Z 0.02 p***<0.001 p***<0.001
PVDS: perivenous tissue destruction scale. p*: comparison between gr
p***: comparison between group 2 and group 3.7) of the vein wall will be the result. The maximum
temperatures measured near the vein wall reached in
excess of 100 C. These measurements, however, were
rather exceptional. Conversely, the tumescent liquid
around the vein acts as a ‘heat sink’ to protect the peri-
venous tissues. However, it also limits the temperature rise
in the vein wall and possibly prevents perforations in that
way. This may explain why we saw only a limited number of
perforations (5/109 sections) in the third group.
The temperature measurement did not differ signifi-
cantly between the three groups, but there was a wide
range of measurements. This was due to the position of the
thermocouples. The thermocouples used were very thin
and very difficult to localise under ultrasound control. The
thermocouples also had to be fixed to the skin because they
moved easily. If the thermocouples are not always posi-
tioned at exactly the same distance from the vein wall,
then comparison between the various groups is impossible.
We removed all the veins 1 week after treatment
because the extent of vein wall destruction and perivenous
tissue destruction cannot be assessed in veins harvested
immediately after treatment, but only in samples removed
later.18,23 Absorption is the primary event that allowsoup1: Anti-Trendelenburg position, Group 2: Trendelenburg
Adventitial
destruction
Total vein wall
destruction
PVDS:/15
)
37.48%
(SD Z 38.36)
61.25%
(SD Z 29.25)
7.17 (SD Z 2.63)
)
45.83%
(SD Z 43.57)
65.92%
(SD Z 29.46)
8.70 (SD Z 1.51)
)
64.59%
(SD Z 39.89)
81.83%
(SD Z 22.24)
5.83 (SD Z 1.15)
p* Z 0.13 p* Z 0.23 p*<0.001
p**<0.001 p**<0.001 p**<0.001
p***<0.001 p***<0.001 p***<0.001
oup 1 and group 2; p**: comparison between group 1 and group 3;
Figure 5 Perivenous nerve destruction with formation of the
necro-inflammatory tissue infiltrating thenerve (vein 2: group1).
Figure 7 Complete disintegration of the vein wall after
EVLA (vein 12, group 2).
Endovenous Laser Ablation 125a laser or other light source to cause a potentially thera-
peutic (or damaging) effect on a tissue. If the temperature
rises above 42 C, protein denaturation begins. Due to
the transformation of light energy into thermal energy, the
temperature in and around the treated veins rises.27,28 The
vein wall cells are heated, their intracellular proteins
denature and the cells become necrotic. This cannot be
detected histologically until sufficient time has elapsed to
allow inflammatory and tissue repair processes to begin. If
the veins are removed several weeks after treatment, then
the tissues are diffusely infiltrated by necro-inflammatory
tissue and the exact border of necrotic tissue is often
difficult to establish. The process of perivenous tissue
destruction at that time may be in regression due to the
healing process.23
When we measured the destruction of the vein wall, we
found a significantly higher intimal destruction in the third
group. Since residual islands of endothelial cells can
promote recanalisations,18 a higher percentage of circum-
ferential endothelial destruction will minimise that risk.
After a successful EVLA, the treated vein will show anFigure 6 Partial vein wall destruction of a collateral vein at
a distance of 2 mm from the target vein (vein 14, group 2).important shrinkage and evolves into a fibrotic cord.12 This
fibrotic process18,23,29 is initiated by the formation of an
inflammatory tissue surrounding the vein and an infiltration
of fibroblasts and macrophages. This cell migration results
in resolving the necrosis and transforms it into fibrotic
tissue. A higher amount of media and adventitial vein wall
destruction, as we noticed in the third group, will probably
lead to a more important shrinkage of the treated veins.
We did find a slight but significant correlation between
the remaining intraluminal blood volume (RIBV) (Table 2)
and the total vein wall destruction (Pearson correlation r:
0.306, p < 0.01): the lower the RIBV, the higher the vein
wall destruction. This can be explained by the layer of
carbonised blood around the fibre tip, which hinders the
even distribution of energy to the vein wall. A higher
volume of intraluminal blood will absorb a proportionally
high amount of delivered light energy, limiting the amount
of energy that can reach the vein wall. This also accounts
for the highest PVTD score being achieved by group two,
compared to group one. More energy reaches and passes
the vein wall, leading to perivenous tissue destruction. This
perivenous tissue destruction could clearly be minimised by
injecting the tumescent liquid around the target vein. It
acts as a heat sink for the energy delivered intraluminally,
allowing a higher ‘calculated total vein wall destruction’,
preventing vein wall perforations and minimising the peri-
venous tissue destruction. The injection of tumescent
liquid had a significantly higher influence on the vein
diameter, compared to the Trendelenburg position alone
(ManneWhitney U; p Z 0.001). This resulted in a signifi-
cantly higher fluence (after catheterisation and tumescent
injection) and a higher ‘calculated total vein wall
destruction’ (T-test; p < 0.001). The injection of tumes-
cence minimised the perivenous tissue destruction (T-test:
p < 0.001) and prevented most of the perforations
(p Z 0.02).
The lateral saphenous vein in goats has been used as
a venous model in the previous work in this field.18,23,30
These are not varicose veins and the thickness of the vein
wall is therefore somewhat lower than the thickness of
human varicose veins. Whilst this is a useful model, it does
not replicate human varicose saphenous veins.
126 M.E. Vuylsteke et al.The histological scoring in this trial was carried out by
independent pathologists. The results obtained are some-
times approximate, because the measured destruction was
sometimes unevenly distributed and sometimes the borders
were difficult to establish.
Conclusion
The amount of intraluminal blood during EVLA should be
minimised as much as possible. A higher intraluminal blood
volume results in reduced total vein wall destruction. The
injectionof tumescent liquid lowers theamountof intraluminal
blood, resulting in an increased total vein wall destruction.
Its functions as a heat sink and, in this way, prevents peri-
venous tissue destruction and vein wall perforations.
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